E. Ohman J:or Asset Management’s ResMed RMD Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$978K Hold
5,018
0.02% 297
2026
Q1
$1.13M Sell
5,018
-512
-9% -$128K 0.03% 266
2025
Q4
$1.33M Sell
5,530
-670
-11% -$171K 0.03% 252
2025
Q3
$1.7M Hold
6,200
0.04% 205
2025
Q2
$1.6M Hold
6,200
0.04% 205
2025
Q1
$1.39M Hold
6,200
0.04% 224
2024
Q4
$1.42M Buy
6,200
+700
+13% +$169K 0.03% 228
2024
Q3
$1.34M Sell
5,500
-700
-11% -$156K 0.03% 216
2024
Q2
$1.19M Hold
6,200
0.03% 231
2024
Q1
$1.23M Buy
6,200
+500
+9% +$91.6K 0.03% 223
2023
Q4
$981K Sell
5,700
-1,000
-15% -$154K 0.04% 228
2023
Q3
$991K Hold
6,700
0.04% 245
2023
Q2
$1.46M Buy
6,700
+700
+12% +$156K 0.05% 200
2023
Q1
$1.31M Sell
6,000
-500
-8% -$108K 0.05% 207
2022
Q4
$1.35M Hold
6,500
0.06% 198
2022
Q3
$1.42M Hold
6,500
0.06% 181
2022
Q2
$1.36M Hold
6,500
0.06% 185
2022
Q1
$1.58M Sell
6,500
-900
-12% -$218K 0.05% 205
2021
Q4
$1.93M Buy
7,400
+700
+10% +$182K 0.06% 202
2021
Q3
$1.77M Hold
6,700
0.06% 197
2021
Q2
$1.65M Buy
6,700
+1,400
+26% +$294K 0.05% 215
2021
Q1
$1.03M Buy
5,300
+2,000
+61% +$401K 0.04% 259
2020
Q4
$701K Hold
3,300
0.03% 282
2020
Q3
$566K Sell
3,300
-2,182
-40% -$403K 0.03% 267
2020
Q2
$1.05M Hold
5,482
0.06% 156
2020
Q1
$807K Sell
5,482
-1,400
-20% -$223K 0.06% 150
2019
Q4
$1.07M Buy
6,882
+582
+9% +$83.9K 0.06% 187
2019
Q3
$851K Hold
6,300
0.05% 184
2019
Q2
$769K Buy
6,300
+1,700
+37% +$188K 0.05% 197
2019
Q1
$478K Sell
4,600
-1,000
-18% -$103K 0.03% 249
2018
Q4
$638K Sell
5,600
-1,100
-16% -$118K 0.05% 200
2018
Q3
$773K Buy
6,700
+1,000
+18% +$110K 0.05% 197
2018
Q2
$590K Buy
5,700
+1,400
+33% +$142K 0.04% 219
2018
Q1
$423K Hold
4,300
0.03% 281
2017
Q4
$364K Buy
4,300
+700
+19% +$57.8K 0.03% 342
2017
Q3
$277K Buy
3,600
+200
+6% +$15.3K 0.02% 376
2017
Q2
$265K Hold
3,400
0.03% 367
2017
Q1
$245K Hold
3,400
0.03% 382
2016
Q4
$211K Hold
3,400
0.03% 397
2016
Q3
$220K Hold
3,400
0.03% 358
2016
Q2
$215K Buy
3,400
+1,800
+113% +$106K 0.04% 336
2016
Q1
$92.5K Sell
1,600
-2,000
-56% -$113K 0.02% 492
2015
Q4
$193K Hold
3,600
0.03% 355
2015
Q3
$183K Hold
3,600
0.05% 349
2015
Q2
$203K Hold
3,600
0.05% 350
2015
Q1
$258K Hold
3,600
0.06% 302
2014
Q4
$204K Hold
3,600
0.05% 368
2014
Q3
$177K Hold
3,600
0.04% 383
2014
Q2
$182K Hold
3,600
0.04% 386
2014
Q1
$161K Hold
3,600
0.04% 409
2013
Q4
$170K Hold
3,600
0.04% 404
2013
Q3
$190K Hold
3,600
0.05% 380
2013
Q2
$162K Buy
+3,600
New +$171K 0.04% 391

Other funds holding RMD

E. Ohman J:or Asset Management's RMD Position: Q2 2026 in Review

E. Ohman J:or Asset Management held its ResMed (RMD) position steady in Q2 2026 at 5,018 shares worth $978K. The position accounts for 0.02% of the portfolio, ranked #297.

E. Ohman J:or Asset Management first reported a position in RMD in Q2 2013 and has held it in 53 quarters since. The position peaked at $1.93M in Q4 2021. 143 funds tracked by Wall St. Rank hold RMD as of Q2 2026.

  • E. Ohman J:or Asset Management held 5,018 shares of ResMed worth $978K as of Q2 2026.
  • E. Ohman J:or Asset Management left its ResMed share count unchanged in Q2 2026.
  • ResMed made up 0.02% of E. Ohman J:or Asset Management's portfolio in Q2 2026, its #297 holding.
  • E. Ohman J:or Asset Management first reported a position in ResMed in Q2 2013 and has held it in 53 quarters since.
  • E. Ohman J:or Asset Management's ResMed position peaked at $1.93M in Q4 2021.
  • 143 funds tracked by Wall St. Rank held ResMed as of Q2 2026.

Based on E. Ohman J:or Asset Management's 13F filing for Q2 2026, filed 10 Jul 2026.